Skip to main content
Assets
Northrop Grumman logo
NOC.NYSE
Northrop Grumman
Industrials · Aerospace & Defense

Global aerospace and defense technology company providing innovative systems, products, and solutions.

HQ: United StatesListed: United States

Historical AI Consensus

Audit every published iPulse AI forecast batch and immutable historical research document for Northrop Grumman.

Historical AI Consensus

This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.

Symbol
NOC.NYSE
Batch
7
Published
September 20, 2026
AI Advisors
14

Historical AI Consensus Investment Thesis

Northrop Grumman (NOC) Stock Forecast and AI Rating

Deep analysis published Original pricing snapshot 12 min read
Published 1-Year and 5-Year Forecast Outlook

Forecast targets and rating

Published batch rating

BUY

Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.

2027

1-Year

BUY

$582

+10.3%+11.6% incl. dividends
2031

5-Year

BUY

$828

+56.9%+66.6% incl. dividends

Published batch insight

Strategic Nuclear Modernization Monopoly Drives Long-Cycle Sovereign Compounding Cash Expansion

High consensus confirms the prime contractor's unassailable monopoly across strategic nuclear triad modernization, supported by a record $104 billion backlog. The primary friction stems from elevated capital expenditures and fixed-price cost absorption, though production scaling will gradually expand structural free cash flow.

Deep Forecast Analysis by iPulse AI Engine

This analysis preserves the original published batch. Audit published forecasts in full transparency

Machiavelli (Insider) advisor portraitSuperintelligence (Anthropologist) advisor portraitJ.P. Morgan (Titan) advisor portraitUniversal Investor (Polymath) advisor portraitWarren Buffett (Value Purist) advisor portraitElon Musk (Visionary) advisor portraitRay Dalio (Strategist) advisor portraitMichael Burry (Vulture) advisor portraitSherlock Holmes (Whistleblower) advisor portrait

Machiavelli (Insider), Superintelligence (Anthropologist), J.P. Morgan (Titan), Universal Investor (Polymath), Warren Buffett (Value Purist), Elon Musk (Visionary), Ray Dalio (Strategist), Michael Burry (Vulture), Sherlock Holmes (Whistleblower). Some archetypes run in multiple modes, resulting in 14 advisors total.

Computed on these frontier AI models
Gemini AI model logoGeminiClaude AI model logoClaudeChatGPT AI model logoChatGPT

Full published thesis

Executive Summary

If you invested $10,000 in Northrop Grumman at the forecast anchor (2026-09-18): $16,658 in five years versus $13,892 for S&P 500 benchmark.

Five-year synthesized consensus forecast for Northrop GrummanThe diagram shows the synthesized consensus value path for Northrop Grumman, forecast milestones, and a comparison with S&P 500 benchmark. including estimated net dividends of 1.2% per year.$10,000$15,000$16,658 (+66.6%)$13,892 (+38.9%)Anchor2026-09-182027(1Y)2028(2Y)2029(3Y)2030(4Y)2031(5Y)
Northrop Grumman · Synthesized ConsensusS&P 500 benchmark

* Return is calculated incl. 1.2% net dividend yield for Northrop Grumman.

Figure: Five-year synthesized consensus value path for Northrop Grumman compared with S&P 500 benchmark. The path uses the synthesizer’s normalized opinion weights.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each step

Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.

Anchor: 527.39 USD1-year price return: +10.31%5-year price return: +56.93%

Swipe the table horizontally to read every column.

Twenty quarterly synthesized price forecasts in USD, with returns and rationale
QuarterTarget (USD)Quarter returnTotal returnForecast rationale
Q4 2026539.92+2.38%+2.38%Defense appropriations confirm solid funding for strategic deterrence programs. Strong fourth-quarter milestone receipts support cash generation, but elevated capital spending and discount rate pressures limit valuation expansion to a modest gain.
Q1 2027554.89+2.77%+5.21%Full-year reporting confirms record backlog above $105 billion, while forward guidance establishes cautious production-phase margin repair. Capital commitments for factory tooling restrain immediate buybacks, supporting steady but measured share price appreciation.
Q2 2027572.80+3.23%+8.61%Initial operational B-21 delivery milestones and progress on restructured Sentinel ground infrastructure de-risk execution. Margin stability in Mission Systems offsets ongoing development absorption, driving moderate institutional re-weighting.
Q3 2027581.76+1.56%+10.31%Congressional debates over federal budget caps and seasonal continuing resolution friction create temporary procurement pauses. Healthy munition replenishment orders provide downside support, holding share price movement to modest consolidation.
Q4 2027603.19+3.68%+14.37%Enacted defense appropriations solidify funding for low-rate initial bomber lots and rocket propulsion facilities. Operating cash flow improves seasonally into year-end, validating steady backlog conversion despite tight monetary conditions.
Q1 2028613.94+1.78%+16.41%Annual results demonstrate Aeronautics segment margin recovery as early manufacturing friction abates. Capex guidance remains elevated, signaling continued investment in physical capacity and keeping share appreciation on a disciplined, gradual trajectory.
Q2 2028631.38+2.84%+19.72%Maiden Sentinel flight evaluation milestones validate booster stage integration, reducing catastrophic technical tail risk. Expanding foreign military sales of radar and battle command suites provide incremental operational margin support.
Q3 2028637.64+0.99%+20.90%Election-cycle fiscal rhetoric creates brief sector-wide multiple compression, but non-discretionary nuclear modernization contracts shield core revenue. High capacity utilization in solid rocket motor foundries preserves solid through-cycle earnings.
Q4 2028658.15+3.22%+24.79%Legislative continuity reaffirms multi-year procurement schedules across strategic platforms. Capital expenditure intensity begins approaching its peak, prompting expectations of improving free cash flow and driving solid fourth-quarter equity appreciation.
Q1 2029672.95+2.25%+27.60%Full-year results confirm free cash flow expanding as major factory construction winds down. Management signals potential resumption of share buybacks, reinforcing earnings-per-share compounding and providing reliable price support.
Q2 2029691.87+2.81%+31.19%Higher-rate B-21 manufacturing lots unlock measurable factory learning-curve efficiencies. Aeronautics operating margins advance toward double-digit targets, driving solid operating earnings growth and positive analyst estimate revisions.
Q3 2029701.73+1.43%+33.06%International defense sales expand toward long-term targets as European and Pacific allies procure integrated air defense nodes. High-margin export deliveries buffer domestic wage pressures, maintaining steady quarterly compounding.
Q4 2029721.67+2.84%+36.84%Sustained cash conversion allows accelerated debt retirement alongside modest treasury share repurchases. Solid year-end progress payments across classified space and aeronautics programs reinforce durable multi-year top-line momentum.
Q1 2030734.82+1.82%+39.33%Annual financial disclosures confirm consolidated operating margins crossing eleven percent. Moderating capital requirements unlock substantial owner earnings, driving steady valuation gains as operational delivery replaces development overhang.
Q2 2030748.35+1.84%+41.90%Sentinel silo modernization and propulsion deployment scale across strategic bases, sustaining steady Defense Systems top-line expansion. Commercial and military launch partnerships maintain elevated factory throughput in rocket motors.
Q3 2030761.32+1.73%+44.36%Stable defense appropriations protect long-duration programmatic backlogs from broader macroeconomic slowdowns. Disciplined capital allocation and growing recurring sustainment billings provide defensive equity stability through late-summer procurement lulls.
Q4 2030782.65+2.80%+48.40%Strong operational execution delivers robust free cash flow, enabling regular dividend increases and consistent open-market share retirements. Institutional accumulation of resilient sovereign cash flows propels shares higher into year-end.
Q1 2031795.90+1.69%+50.91%First-quarter operational reports confirm steady manufacturing throughput and favorable contract mix. High-margin mission electronics and international munitions orders cushion seasonal working capital outlays, preserving steady equity compounding.
Q2 2031812.92+2.14%+54.14%Foreign military sales approach targeted milestones, contributing richer operating profitability than domestic baseline development work. Ample liquidity and pristine interest coverage comfortably support ongoing shareholder distributions.
Q3 2031827.65+1.81%+56.93%The five-year modernization horizon concludes with mature production across strategic strike and missile programs. Compound earnings growth and sustained franchise defense moats deliver a durable, cash-backed valuation expansion.

Northrop Grumman represents a non-discretionary sovereign defense monopoly navigating a multi-year transition from capital-intensive engineering development into serialized production. The base-case economic argument centers on the monetization of an irreplaceable dual-leg nuclear triad franchise, anchored by the B-21 Raider and Sentinel ICBM programs, within an enterprise firm backlog exceeding $104 billion. While elevated discount rates and a 5% long-bond yield compress long-duration defense multiples, top-line growth is legally insulated from commercial macro volatility. The strongest counterargument highlights persistent fixed-price estimate-at-completion vulnerability, specialized labor wage inflation, and management's guided capital intensity near 4.5% of revenue through 2028, which has temporarily paused share repurchases and deferred distributable cash conversion.

Key insights

  • Production learning curves will gradually displace early low-rate initial production cost dilution, expanding consolidated operating margins toward 11% by late decade.
  • Self-funded capacity expenditures of $2.5 billion require disciplined patience, converting into superior operating leverage only after serial manufacturing rates achieve steady-state cadence.
  • Statutory restructuring of Sentinel into cost-reimbursable engineering frameworks neutralizes existential cancellation risk while capping peak achievable contract profit margins.

Deep Dive

The prevailing market crowd treats Northrop Grumman as an unexciting defense utility whose valuation is constrained by federal deficit friction, continuing resolutions, and legacy fixed-price contract write-downs. Consensus fixates on Nunn-McCurdy cost overruns and sticky supply-chain inflation, treating the stock as a low-beta bond proxy and pricing shares at an undemanding trailing multiple while overlooking structural backlog inflection.